Effect of Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine on Exacerbation Rate and Risk in Patients With Moderate to Severe COPD
Author:
Frank C. Sciurba,Stephanie A. Christenson,Tara Rheault,Thomas Bengtsson,Kathleen Rickard,Igor Z. Barjaktarevic
© 2024 The Author(s). Published by Elsevier Inc under license from the American College of Chest Physicians.